Search for: "Hospira" Results 161 - 180 of 487
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Sep 2016, 1:10 pm
A closer look at Hospira v Cubist and daptomycin micellesIPKat returns to the Hospira v Cubist case to look in more detail at the claim relating to purifying daptomycin by altering by PH.* My My Mylan: The Trademark Silver Lining for Mylan's EPIPENMylan has recently come under fire for raising the price of the EPIPEN. [read post]
15 Oct 2010, 10:29 am by Brian Evans
  Hospira’s spokesman Dainel Rosenberg to the Arizona Republic, “The expiration dates for lots last manufactured by Hospira are for 2011. [read post]
10 Feb 2011, 5:49 am
In September, Hospira filed a suit in the United States District Court for Northern Illinois (Case Number 1:2010cv06275) seeking a declaratory judgment stating that Hospira is not infringing Lilly's patent. [read post]
2 Nov 2012, 9:44 am
Hospira officials are accused of failing to maintain equipment and firing seasoned employees associated with Project Fuel. [read post]
14 Sep 2022, 12:42 am by Rose Hughes
 Second, even if a product-by-process claim for a medical device is achieved, the enforceability of such a claim represents a challenge in and of itself (Hospira v Genentech ([2014] EWHC 3857, IPKat)). [read post]
22 Jan 2011, 10:08 am by Brian Evans
In this case, Hospira has opted out, reiterating in its statement that capital punishment is “a use Hospira has never condoned” for their drug, and lamenting that “our many hospital customers who use the drug for its well-established medical benefits will not be able to obtain the product. [read post]
24 Jan 2011, 12:31 pm by Eric Schweibenz
The complaint alleges that the gemcitabine active pharmaceutical ingredient is manufactured outside the United States by Hansoh using the infringing Sn2 process, which is then shipped to India for formulation into Hospira’s generic gemcitabine pharmaceutical product by Intas, finally being imported into and sold in the United States by Respondents, including at least ChemWerth and Hospira. [read post]
30 Aug 2016, 7:52 am
Hospira alleged that the patent was not entitled to either of its priority dates. [read post]
28 Jan 2011, 9:06 am by Steve Hall
Saying it could not make such guarantees, Hospira opted to abandon the product. [read post]
20 Oct 2010, 1:43 pm by Steve Hall
Hospira is currently not making the drug and it is in short supply nationally. [read post]
16 Sep 2020, 10:02 am by Pete Strom
Richard Breland, the Hospira service representative, was also dismissed as a defendant before the trial started. [read post]
19 Apr 2010, 1:10 pm by John J. Cord
Hospira: Drug-maker Hospira received two FDA warning letters about manufacturing problems. [read post]
11 Feb 2011, 8:31 am by Steve Hall
Hospira decided to stop making thiopental entirely; it had planned to move thiopental manufacturing to an Italian plant, but government officials there threatened action if Hospira didn't block its use in executions. [read post]
1 Dec 2009, 8:54 am
Hospira Healthcare Corporation, sanofi responded to Hospira’s NOA by filing a disclaimer in respect of a portion of one of sanofi’s listed patents. [read post]